Source - RNS
RNS Number : 8363I
Carclo plc
02 September 2016




For immediate release                                                                                         2 September 2016



Carclo plc


Result of AGM Resolutions



Carclo plc announces that all resolutions proposed at the Annual General Meeting yesterday were passed on a show of hands. Resolution 3, set out in the Notice of the AGM, relating to the declaration of a final dividend, had become redundant in the light of the Company's announcement made on 31 August 2016, and was therefore, with the approval of the meeting, not proposed to the shareholders. 


In accordance with Listing Rule 9.6.2, copies of the resolutions passed as special business will be submitted to the UK Listing Authority via the National Storage Mechanism, which can be accessed at


The items of special business approved at the AGM were:


(i)         authority to allot shares pursuant to Section 551 of the Companies Act 2006.


(ii)        Disapplication of pre-emption rights upon the allotment of equity securities for cash pursuant to Section 570 of the Companies Act 2006.


(iii)       authority to make market purchases of shares pursuant to Section 701 of the Companies Act 2006.


(iv)       approval to call general meetings (other than annual general meetings) on 14 clear days' notice.



A half year trading update will be issued during the week commencing 10 October 2016.


- ENDS -



Carclo plc

01924 268040

Chris Malley, Chief Executive

Robert Brooksbank, Finance Director

Weber Shandwick Financial

020 7067 0700

Nick Oborne  




Notes to editors


Carclo plc is a public company whose shares are quoted on the London Stock Exchange.


Carclo's strategy is to develop and expand its key manufacturing assets where there remain significant further opportunities to drive value. To enhance profit margins and support customers the Group has been investing in lower cost regions and new technologies.


Approximately three fifths of Group revenues are derived from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the low volume premium automotive industry.


This information is provided by RNS
The company news service from the London Stock Exchange